Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease

Inflammatory bowel disease (IBD) is the chronic inflammatory disorder of gastrointestinal tract consisting of two subtypes: Ulcerative colitis and Crohn's disease. IBD occurs due to infiltration of leukocytes in intestinal mucosa and derangements in intestinal barrier function. One of the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Harmanjit, Grewal, Nipunjot, Arora, Ekta, Kumar, Harish, Kakkar, Ashish Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780165/
https://www.ncbi.nlm.nih.gov/pubmed/27003961
http://dx.doi.org/10.4103/0976-9668.175016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780165/
https://www.ncbi.nlm.nih.gov/pubmed/27003961
http://dx.doi.org/10.4103/0976-9668.175016

Ejemplares similares